Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
Blockchain supply chain business smart contract solution network protocol - illustration rendering | Image Credit - © immimagery - © immimagery - stock.adobe.com
With the bio/pharmaceutical industry facing patent expirations in the near-term for key drugs, bio/pharma companies are facing the pressure of staying competitive in a bio/pharmaceutical landscape where the therapies are growing increasingly complex amid a major shift toward personalized medicines. Pharmaceutical Technology® spoke with Informa Markets about the critical role outsourcing plays in today’s competitive environment as well as into the future.
Read this article in Pharmaceutical Technology’s Bio/Pharma Outsourcing Innovation eBook.
Chris Spivey is the editorial director of Pharmaceutical Technology® and Pharmaceutical Technology Europe®.
Pharmaceutical Technology/Pharmaceutical Technology Europe Outsourcing Innovation eBook
Issue 2
February 2024
Pages: 31-32
When referring to this article, please cite it as Spivey, C. Pharmaceutical Outsourcing Present and Future. Pharmaceutical Technology, Bio/Pharma Outsourcing Innovation eBook. February 2024.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.